Pharming Group NV (PHAR) — Strategic Asset Allocation Index
Pharming Group NV (PHAR) has a Strategic Asset Allocation Index of 3.1% as of December 2025. Strategic assets (PP&E of $- plus long-term investments of $8.65 Million) total $8.65 Million, measured against net assets of $277.02 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. Check Pharming Group NV (PHAR) asset resilience to evaluate the company's liquid asset resilience ratio.
SAAI
Strategic Assets
PP&E
Net Assets
Pharming Group NV Strategic Asset Allocation Index (2017–2025)
This chart shows how Pharming Group NV's Strategic Asset Allocation Index has evolved across 9 annual periods from 2017 to 2025. As of December 2025, the index stands at 3.1%, representing strategic assets of $8.65 Million against net assets of $277.02 Million USD. See financial agility of Pharming Group NV to measure the company's free cash flow as a share of total liabilities.
Annual Strategic Asset Allocation Index for Pharming Group NV (2017–2025)
The table below presents the year-by-year Strategic Asset Allocation Index for Pharming Group NV from 2017 to 2025, covering 9 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see market cap of Pharming Group NV.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 3.1% | $8.65 Million | $- | $8.65 Million | $277.02 Million | ▲ +1.2 pp |
| 2024 | 1.9% | $4.23 Million | $- | $4.23 Million | $221.06 Million | ▼ -2.8 pp |
| 2023 | 4.8% | $10.40 Million | $- | $10.40 Million | $218.78 Million | ▼ -19.1 pp |
| 2022 | 23.9% | $48.88 Million | $39.15 Million | $9.73 Million | $204.64 Million | ▲ +4.2 pp |
| 2021 | 19.7% | $38.05 Million | $29.26 Million | $8.79 Million | $192.92 Million | ▲ +4.1 pp |
| 2020 | 15.6% | $23.43 Million | $17.63 Million | $5.80 Million | $150.16 Million | ▼ -1.5 pp |
| 2019 | 17.1% | $20.04 Million | $14.53 Million | $5.51 Million | $117.39 Million | ▲ +5.2 pp |
| 2018 | 11.9% | $8.40 Million | $8.40 Million | $- | $70.64 Million | ▼ -24.6 pp |
| 2017 | 36.5% | $8.23 Million | $8.23 Million | $- | $22.56 Million | — |